Furthermore, Multiple sclerosis, which is an autoimmune disease characterized by chronic inflammation of the central nervous system, revealed low expression levels of lncRNA MEG3 in relapsing phase patients in comparison to patients in remission and control groups (Torkamandi et al. 2021). This evidence concerns the gene MEG3 and multiple sclerosis.